Header Logo

Connection

Alan Go to Hydroxymethylglutaryl-CoA Reductase Inhibitors

Back to Details
This is a "connection" page, showing publications Alan Go has written about Hydroxymethylglutaryl-CoA Reductase Inhibitors.
Alan Go
Connection Strength
3.692
Hydroxymethylglutaryl-CoA Reductase Inhibitors
  1. Triglyceride Levels and Residual Risk of Atherosclerotic Cardiovascular Disease Events and Death in Adults Receiving Statin Therapy for Primary or Secondary Prevention: Insights From the KP REACH Study. J Am Heart Assoc. 2021 10 19; 10(20):e020377.
    View in: PubMed
    Score: 0.683
  2. Statin Therapy and Risk of Incident Diabetes Mellitus in Adults With Cardiovascular Risk Factors. Am J Cardiol. 2020 02 15; 125(4):534-541.
    View in: PubMed
    Score: 0.599
  3. Contemporary rates and correlates of statin use and adherence in nondiabetic adults with cardiovascular risk factors: The KP CHAMP study. Am Heart J. 2017 Dec; 194:25-38.
    View in: PubMed
    Score: 0.513
  4. Use of medications for secondary prevention after coronary bypass surgery compared with percutaneous coronary intervention. J Am Coll Cardiol. 2013 Jan 22; 61(3):295-301.
    View in: PubMed
    Score: 0.371
  5. Statin therapy and risks for death and hospitalization in chronic heart failure. JAMA. 2006 Nov 01; 296(17):2105-11.
    View in: PubMed
    Score: 0.243
  6. Statin and beta-blocker therapy and the initial presentation of coronary heart disease. Ann Intern Med. 2006 Feb 21; 144(4):229-38.
    View in: PubMed
    Score: 0.231
  7. Performance of the pooled cohort equation in South Asians: insights from a large integrated healthcare delivery system. BMC Cardiovasc Disord. 2022 12 23; 22(1):566.
    View in: PubMed
    Score: 0.186
  8. Rationale and design of the pragmatic randomized trial of icosapent ethyl for high cardiovascular risk adults (MITIGATE). Am Heart J. 2021 05; 235:54-64.
    View in: PubMed
    Score: 0.163
  9. Use of Statins in Adults Older Than 75 Years-Reply. JAMA. 2017 03 14; 317(10):1081.
    View in: PubMed
    Score: 0.124
  10. Statins for Primary Prevention in Older Adults: Uncertainty and the Need for More Evidence. JAMA. 2016 Nov 15; 316(19):1971-1972.
    View in: PubMed
    Score: 0.122
  11. Accuracy of the Atherosclerotic Cardiovascular Risk Equation in a Large Contemporary, Multiethnic Population. J Am Coll Cardiol. 2016 05 10; 67(18):2118-2130.
    View in: PubMed
    Score: 0.117
  12. Comparative Effectiveness of Statin Therapy in Chronic Kidney Disease and Acute Myocardial Infarction: A Retrospective Cohort Study. Am J Med. 2015 Nov; 128(11):1252.e1-1252.e11.
    View in: PubMed
    Score: 0.111
  13. Cost-effectiveness of using high-sensitivity C-reactive protein to identify intermediate- and low-cardiovascular-risk individuals for statin therapy. Circulation. 2010 Oct 12; 122(15):1478-87.
    View in: PubMed
    Score: 0.079
  14. Population trends in the incidence and outcomes of acute myocardial infarction. N Engl J Med. 2010 Jun 10; 362(23):2155-65.
    View in: PubMed
    Score: 0.078
  15. Statin use and risk of basal cell carcinoma. J Am Acad Dermatol. 2009 Jul; 61(1):66-72.
    View in: PubMed
    Score: 0.072

© 2024 Kaiser Permanente